✦ LIBER ✦

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)

✍ Scribed by Richter, Suzanne; Bedard, Philippe L.; Chen, Eric Xueyu; Clarke, Blaise A.; Tran, Ben; Hotte, Sebastien J.; Stathis, Anastasios; Hirte, Hal W.; Razak, Albiruni R. A.; Reedijk, Michael; Chen, Zhuo; Cohen, Brenda; Zhang, Wen-Jiang; Wang, Lisa; Ivy, S. Percy; Moore, Malcolm J.; Oza, Amit M.; Siu, Lillian L.; McWhirter, Elaine

Book ID: 121637915
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 439 KB
Volume: 32
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-013-9965-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase Ib combination study of RO492909

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors

✍ Ivan Diaz-Padilla, Hal Hirte, Amit M. Oza, Blaise A. Clarke, Brenda Cohen, Micha 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 344 KB

A Phase I study of pazopanib in combinat

A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors

✍ Ruth Plummer, Ayman Madi, Melinda Jeffels… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 266 KB

Phase I Study of Oral Gemcitabine Prodru

Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors

✍ Koolen, S. L. W.; Witteveen, P. O.; Jansen, R. S.; Langenberg, M. H. G.; Kroneme 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 378 KB

Phase I study of oral CP-4126, a gemcita

Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors

✍ F. E. Stuurman, E. E. Voest, A. Awada, P. O. Witteveen, T. Bergeland, P.-A. Hals 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 323 KB

588 A First-in-patient Phase I Study of

588 A First-in-patient Phase I Study of the Novel Gamma Secretase Inhibitor PF-03084014 in Patients with Advanced Solid Tumor Malignancies

✍ Messersmith, W.A.; LoRusso, P.M.; Cleary, J.M.; Dasari, A.; Huang, B.; Shaik, N. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Phase I dose-escalation study of AZD7762

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

✍ Sausville, Edward; LoRusso, Patricia; Carducci, Michael; Carter, Judith; Quinn, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 560 KB